Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Since the introduction of the 13-valent pneumococcal conjugate vaccine, a number of studies have demonstrated the limited efficacy of the pneumococcal serotype 3 component of this vaccine. Evidence from seven countries (Denmark, France, Greece, Portugal, Sweden, UK, US) shows limited or no effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Linley, Ezra, Bell, Abigail, Gritzfeld, Jenna F., Borrow, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466091/
https://www.ncbi.nlm.nih.gov/pubmed/30609868
http://dx.doi.org/10.3390/vaccines7010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466091/
https://www.ncbi.nlm.nih.gov/pubmed/30609868
http://dx.doi.org/10.3390/vaccines7010004

Ejemplares similares